Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | CDC25B | P30305 | 3/20 | 0.57 |
| ▸ | MAOA | P21397 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | APAF1 | O14727 | 2/20 | 0.48 |
| ▸ | TDP2 | O95551 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | S100A4 | P26447 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | TERT | O14746 | 1/20 | 0.48 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.48 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL693395 | 0.98 | MEN1 (0.55) | MEN1KMT2ACDC25BMAOARAB9A | |
| SCHEMBL1929100 | 0.93 | MEN1 (0.55) | MEN1KMT2ACDC25BMAOARAB9A | |
| SCHEMBL7148476 | 0.93 | MEN1 (0.43) | MEN1KMT2ACDC25BMAOARAB9A | |
| SCHEMBL9799712 | 0.87 | MEN1 (0.36) | MEN1KMT2ACDC25BMAOARAB9A | |
| SCHEMBL8659735 | 0.80 | ADORA2A (0.41) | MEN1KMT2ACDC25BMAOARAB9A | |
| SCHEMBL20774014 | 0.79 | MEN1 (0.36) | MEN1KMT2ACDC25BMAOARAB9A | |
| SCHEMBL1350657 | 0.79 | MEN1 (0.36) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL9208192 | 0.79 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL6415478 | 0.79 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A | |
| Anthraquinone SCHEMBL30692662 | 0.79 | MEN1 (0.92) | MEN1KMT2ACDC25BMAOARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 386 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11897977-B2 | Photolabile barbiturate compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-02-13 | — | — | US | claimed |
| US-11370940-B2 | Adhesive article and methods of making and using the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-06-28 | — | — | US | claimed |
| EP-3746489-B1 | PHOTOLABILE BARBITURATE COMPOUNDS | 3M INNOVATIVE PROPERTIES CO (US) | 2022-03-30 | — | — | EP | claimed |
| US-20210277283-A1 | ADHESIVE ARTICLE AND METHODS OF MAKING AND USING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2021-09-09 | — | — | US | claimed |
| CN-108348403-B | Redox polymerizable compositions containing photolabile transition metal complexes | 3M创新有限公司 | 2021-06-18 | — | — | CN | claimed |
| CN-108348404-B | Redox polymerizable dental compositions utilizing photolabile transition metal complexes | 3M创新有限公司 | 2021-06-08 | — | — | CN | claimed |
| CN-110709486-B | Adhesive articles and methods of making and using the same | 3M创新有限公司 | 2021-04-16 | — | — | CN | claimed |
| US-20210040240-A1 | PHOTOLABILE BARBITURATE COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY | 2021-02-11 | — | — | US | claimed |
| EP-3746489-A1 | PHOTOLABILE BARBITURATE COMPOUNDS | 3M Innovative Properties Company (US) | 2020-12-09 | — | — | EP | claimed |
| EP-3746490-A1 | PHOTOLABILE BETA-DICARBONYL COMPOUNDS | 3M Innovative Properties Company (US) | 2020-12-09 | — | — | EP | claimed |
| EP-0479892-A1 | FUSED-RING ARYL SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-15 | — | — | EP | claimed |
| EP-0275077-B1 | ANTHRAQUINONE COMPOUNDS AND POLARIZING FILM CONTAINING THE SAME | MITSUBISHI KASEI CORPORATION (JP) | 1992-02-05 | — | — | EP | claimed |
| WO-1991015206-A1 | TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION WITH IMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-17 | — | — | WO | claimed |
| WO-1991014367-A1 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WITH IMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-03 | — | — | WO | claimed |
| WO-1991000281-A2 | FUSED-RING ARYL SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-10 | — | — | WO | claimed |
| US-4921959-A | POLARIZING FILMS, DICHROMISM | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1990-05-01 | — | — | US | claimed |
| EP-0275077-A1 | Anthraquinone compounds and polarizing film containing the same | MITSUBISHI KASEI CORPORATION (JP) | 1988-07-20 | — | — | EP | claimed |
| EP-0019285-B1 | PROCESS FOR PREPARING ASYMMETRICAL VAT DYESTUFFS OF THE ANTHRAQUINONE SERIES AND THEIR USE IN DYEING AND PRINTING | CIBA-GEIGY AG (CH) | 1984-05-09 | — | — | EP | claimed |
| US-4329456-A | ACYLATION WITHOUT INTERMEDIATE ISOLATION | CIBA-GEIGY AG (CH) | 1982-05-11 | — | — | US | claimed |
| US-4052371-A | AZO PIGMENT OR DYE HAVING A NAPHTHYL-QUINAZALONE COUPLING COMPONENT | BASF AKTIENGESELLSCHAFT (DT) | 1977-10-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11897977-B2 | Photolabile barbiturate compounds | PPOX, CBR1, CBR3 | MEN1 4096/4885KMT2A 3332/4885CDC25B 1466/4885 |
| US-20210040240-A1 | PHOTOLABILE BARBITURATE COMPOUNDS | PPOX, CBR1, CBR3 | MEN1 4096/4885KMT2A 3332/4885CDC25B 1466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.